Literature DB >> 12740738

Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study.

E van Breda1, H A Keizer, H Kuipers, B H R Wolffenbuttel.   

Abstract

The data of the present case demonstrate that the abuse of androgenic anabolic steroids (AAS) may lead to serious health effects. Although most clinical attention is usually directed towards peripheral side effects, the most serious central side effect, hypothalamic-pituitary-dysfunction, is often overlooked in severe cases. Although this latter central side-effect usually recovers spontaneously when AAS intake is discontinued, the present case shows that spontaneous recovery does not always take place. We suggest that hypothalamic-pituitary dysfunction should always be considered in the differential diagnosis in athletes seen with typical presentation of anabolic steroid use. In order to regain normal hypothalamic-pituitary function, supraphysiological doses of 200 microg LH-RH should be considered when the physiological challenge test with LH-RH (50 microg) fails to show an acceptable response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740738     DOI: 10.1055/s-2003-39089

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  14 in total

Review 1.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

Review 2.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 3.  Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2010-02-25       Impact factor: 4.492

Review 4.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

Review 5.  The diagnostic dilemma of pathological appearance and performance enhancing drug use.

Authors:  Tom Hildebrandt; Justine K Lai; James W Langenbucher; Melanie Schneider; Rachel Yehuda; Donald W Pfaff
Journal:  Drug Alcohol Depend       Date:  2010-11-05       Impact factor: 4.492

6.  Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.

Authors:  Gen Kanayama; James I Hudson; James DeLuca; Stephanie Isaacs; Aaron Baggish; Rory Weiner; Shalender Bhasin; Harrison G Pope
Journal:  Addiction       Date:  2015-02-25       Impact factor: 6.526

Review 7.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 8.  Gonadotropins in doping: pharmacological basis and detection of illicit use.

Authors:  U-H Stenman; K Hotakainen; H Alfthan
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

9.  Spontaneous corpus cavernosum abscess in a healthy man using long-term androgenic anabolic steroids.

Authors:  Emre Tüzel
Journal:  World J Mens Health       Date:  2015-04-23       Impact factor: 5.400

10.  Modulatory effect of gonadotropins on rats' ovaries after nandrolone decanoate administration: a stereological study.

Authors:  Hossein Bordbar; Fakhroddin Mesbah; Tahereh Talaei; Farzaneh Dehghani; Hossein Mirkhani
Journal:  Iran J Med Sci       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.